P

Inventor

TAKAMI KAZUAKI

JP21 patents
⚠️ This page may combine multiple inventors who share the name “TAKAMI KAZUAKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAKEDA PHARMACEUTICALS CO

19 patents
US10214498B2Feb 26, 2019

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO4 citations83
US9890145B2Feb 13, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO8 citations82
US11560372B2Jan 24, 2023

Heterocyclic compounds useful as modulators of acetylcholine receptors

TAKEDA PHARMACEUTICALS CO2 citations73
US10975043B2Apr 13, 2021

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO1 citations72
US10807987B2Oct 20, 2020

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO5 citations72
US10544111B2Jan 28, 2020

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO3 citations72
US9975903B2May 22, 2018

Condensed heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations72
US11236099B2Feb 1, 2022

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO4 citations71
US11186565B2Nov 30, 2021

Aromatic compound

TAKEDA PHARMACEUTICALS CO3 citations71
US12024505B2Jul 2, 2024

Heterocyclic compounds useful as modulators of acetylcholine receptors

TAKEDA PHARMACEUTICALS CO0 citations62
US11970483B2Apr 30, 2024

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations62
US11407748B2Aug 9, 2022

Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function

TAKEDA PHARMACEUTICALS CO1 citations62
US12378256B2Aug 5, 2025

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations61
US11702419B2Jul 18, 2023

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO1 citations61
US12162864B2Dec 10, 2024

Condensed-cyclic compound

TAKEDA PHARMACEUTICALS CO0 citations60
US9944596B2Apr 17, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations51
US12590086B2Mar 31, 2026

3-((1H-pyrazol-4-yl)methyl)-6′-(phenyl)-2H-(1,2′-bipyridin)-2-one derivatives and related compounds as GPR139 antagonists for use in a method of treatment of e.g. depression

TAKEDA PHARMACEUTICALS CO0 citations50
US12528802B2Jan 20, 2026

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations49
US11459325B2Oct 4, 2022

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations49

TAKEDA PHARMACEUTICAL

1 patent

UJIKAWA OSAMU

1 patent